Pharmacokinetics of IGF-1 LR3 The extended half-life of IGF-1 LR3 stems from two features: the N-terminal extension physically blocks IGFBP binding, and reduced clearance via the IGFBP-ALS ternary complex slows hepatic filtration
Characteristic 2: Age Under 40 Pituitary somatotroph mass and GH pulse amplitude both decline with age
Among the 1,127 participants with prediabetes at baseline in the ATTAIN-1 trial, up to 91% of those taking orforglipron achieved normoglycemia (normal blood sugar levels) at 72 weeks, compared with only 42% of those taking placebo
Uceda, A
Food, sleep, and stress management matter
As health coaches, were now supporting clients across a wider spectrum than ever before: some using GLP-1 medications, some choosing not to, and many moving between those phases over time